UNSPSC 85752105: Revision of autologous tissue substitute in vas deferens, external approach

This classification denotes the group of activities that yields a surgical intervention or procedure to revision of autologous tissue substitute in vas deferens, external approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0VWRX7Z

UNSPSC 85752105 Revision of autologous tissue substitute in vas deferens, external approach is a Commodity code that shows little relevant recent activity. The recent opportunities tagged under this code span independent medical evaluation services, surgical benefit carve-out programs, occupational medical surveillance, youth detention healthcare, pharmacy benefit management, and temporary health professional staffing — none of which align with the code's nominal scope of urologic surgical revision procedures. The mismatch suggests either data-tagging inconsistency in the underlying procurement databases or the code's use as a catch-all placeholder for miscellaneous health and medical services that state and local bodies are buying but have not mapped to more precise taxonomy.

Issuing bodies posting opportunities in this code space include state departments (Washington State Department of Transportation), large counties (Harris County, Collier County, Santa Clara County), and major cities (Phoenix, Long Beach). Geographic activity spans Washington, Arizona, California, Florida, and Texas, though the opportunities themselves reflect general health services procurement rather than the specific urologic procedure the code nominally describes. The City of Phoenix Retirement Office is soliciting independent medical evaluation services for approximately 75 annual disability determinations, with proposals due October 16, 2026 and a maximum five-year contract value of $750,000. The City of Long Beach is requesting proposals for surgical and medical procedure carve-out benefit programs covering knee, hip, orthopedic, shoulder, spine, heart, weight loss, and oncology procedures, with proposals due October 7, 2026 and contract execution targeted for April 1, 2027. Given the code's apparent misuse or broad classification, pursuit depends on whether your firm operates in the general health services or benefits administration space; the code itself does not appear to signal genuine opportunity in urologic device or procedure supply.